Name: Latest research reports of Corona Remedies Ltd. authored by Deven Choksey and published by - Trendlyne research reports.
Item: Corona Remedies Ltd.
Rating: 5
Author: Deven Choksey

Indian Economy

TREND | 08 Dec 2025

RBI maintains a neutral stance with a rate cut while closely monitoring inflation and growth before considering further cuts

Indian Economy

Deven Choksey

The Monetary Policy Committee (MPC) reduced the policy repo rate by 25 bps to 5.25% while maintaining a neutral stance, marking the first easing step of the current cycle.

Trendlyne Analysis released a Economy Update report for Indian Economy on 16 Dec, 2025.

Corona Remedies Ltd.

08 Dec 2025

1374.30

0.58%

IPO Note

IPO Subscribe: Corona Remedies Ltd.

Deven Choksey

The company has undertaken recent acquisitions like Myoril from Sanofi and Spye from Bayer. It is bolstering its gynaecology and cardiology portfolio and executed a partnership with Ferring for Solifenacin.

Corona Remedies has gained 29.41% in the last 3 Months

Wakefit Innovations Ltd.

08 Dec 2025

192.32

-0.31%

IPO Note

IPO Subscribe: Wakefit Innovations Ltd.

Deven Choksey

The company’s future strategy hinges on a multi-pronged approach of product innovation, physical retail expansion, and brand enhancement to capitalize on favorable industry trends and solidify its market leadership.

No SMAs available

Nifty 50

08 Dec 2025

25966.40

0.58%

BAZAAR PULSE

Nifty 50

invest4Edu

MARKET SNAPSHOT

Nifty 50 is trading below its 30 day SMA of 25968.2

Suzlon Energy Ltd.

07 Dec 2025

52.59

1.56%

Adding more wind under its blades

Buy: Suzlon Energy Ltd.

ICICI Securities Limited

Suzlon delivered strong operating metrics in H1FY26. However, the news flow around the new renewable capacity addition has been under weather. In this backdrop, Suzlon’s management highlighted the key positives during its investor day.

Suzlon Energy Ltd. has an average target of 75.80 from 6 brokers.

Bajaj Housing Finance Ltd.

07 Dec 2025

95.31

0.28%

Focus on gaining market share but with emphasis on operating efficiency and credit quality

Buy: Bajaj Housing Finance Ltd.

ICICI Securities Limited

BHFL is among the fastest growing HFCs in India – 29% AUM CAGR between FY20-25 vs. similar-sized peers’ growth declining and larger peer growing at 8% during the same period.

Bajaj Housing Financ.. has an average target of 122.50 from 2 brokers.

Bajaj Finance Ltd.

07 Dec 2025

1008.30

0.80%

Retail credit market share may improve to ~4% led by strategic priority towards customer centricity and AI-enabled process

Hold: Bajaj Finance Ltd.

ICICI Securities Limited

Bajaj Finance’s (BFL) FY26-30 strategic roadmap not only focuses on sustaining high growth but also emphasises on improving profitability.

Bajaj Finance Ltd. has an average target of 1102.86 from 11 brokers.

Suzlon Energy Ltd.

07 Dec 2025

52.59

1.56%

Strong pipeline and export readiness support long-term value creation

Buy: Suzlon Energy Ltd.

Motilal Oswal

Management expects limited impact on near-term order flows from the slowdown in central renewables bidding (~40 GW projects lacking PPAs), highlighting that ~15 GW of wind orders remain in the pipeline (bidding/award stage).

Number of FII/FPI investors decreased from 793 to 763 in Sep 2025 qtr

ITC Hotels Ltd.

06 Dec 2025

193.83

2.18%

Beyond the welcome drink – growth checking in

Buy: ITC Hotels Ltd.

ICICI Securities Limited

We initiate coverage of ITC Hotels Ltd. (ITCHL) with a BUY rating and a target price of INR 250, based on a 27x Dec’27E EV/EBITDA for its hotels business and a 1x NAV for its Sri Lanka residential project.

Number of MF schemes increased from 26 to 33 in Sep 2025 qtr.

Tata Consultancy Services Ltd.

06 Dec 2025

3282.00

0.04%

Pick of the Week:TCS

Buy: Tata Consultancy Services ...

Target

Axis Direct

We recommend a BUY on the stock with a target price of Rs 3,565/share, implying an upside of ~10% from the CMP.

Tata Consultancy Ser.. has an average target of 3621.20 from 10 brokers.